LSD1 deletion in cardiac myofibroblasts attenuates the remodeling induced by transverse aortic constriction, whereas LSD1 deletion in cardiomyocytes triggers mild cardiac hypertrophy and dysfunction [103]. Here, KDM1A is linked to cardiac hypertrophy.